Cancer Screening Market in India (2018-2023)

Publisher Name :
Date: 19-Sep-2018
No. of pages: 90

Cancer screening market in India

The Asia-Pacific is a growing region and holds lots of positive socio-economic factors suitable for the growth and progress of the market primarily because of its association with the global value chains (GVCs). India being a part of the Asia-Pacific region, holds key access t- the region's close association with trade agreements with global growth centers. The total market for diagnostic and medical equipment in India is worth USD 14.73 billion and is forecasted t- expand at an annual rate of 13% CAGR during the forecast period 2018-2023.

Key growth factors

With the growing population, the cancer burden continues t- grow in India. Hence, arises the need of more precision based medical technologies and methodologies t- cater t- the need of the region.

Threats and key players

Though the Indian market is burgeoning with opportunities .It needs t- focus more on its tax regime and easier business conditions. More than 1 million cases of cancer are diagnosed in India every year and this number is bound t- increase by 5 billion. Taking int- considerations the risks, the region is bound t- encounter human and economic costs from the increasing rate of cancer.

The key players operating in the cancer screening market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Siemens Healthineers, Philips and GE Healthcare.

What is covered in the report?

1. Overview of the cancer screening market in India.

2. Market drivers and challenges in the cancer screening market in India.

3. Market trends in the cancer screening market in India.

4. Historical, current and forecasted market size data for segments based on end users (hospitals, laboratories, and independent physicians and clinics).

5. Historical, current and forecasted market size data for segments based on screening type (Laboratory, genetic, biopsy, imaging and endoscopy testing).

6. Historical, current and forecasted market size data for segmentation based on application type (lung, breast, melanoma, kidney and colorectal cancer).

7. Analysis of the competitive landscape and profiles of the major companies operating in the market.

Why buy?

- Understand the demand for cancer screening market in India t- determine the viability of the market.

- Identify the developed and emerging markets where cancer screening market in India is sold.

- Identify the challenge areas and address them.

- Develop strategies based on the drivers, trends and highlights for each of the segments.

- Evaluate the value chain t- determine the workflow and t- get an idea of the current position where you are placed.

- Recognize the key competitors of this market and respond accordingly.

- Knowledge of the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth.

- Define the competitive positioning by comparing the products and services with the key players in the market.

Customizations available

With the given market data, Netscribes offers customizations according t- specific needs. Write t- us at support@researchonglobalmarkets.com.

Cancer Screening Market in India (2018-2023)

Table of Contents

Chapter 1: Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary

Chapter 2: Cancer screening market in India - market overview
2.1. India market overview - market trends, market attractiveness analysis, geography-wise market revenue (USD)
2.2. India - market drivers and challenges
2.3. Value chain analysis - industrial valve market in India
2.4. Porter's five forces analysis

Chapter 3. Cancer screening market in India - by end users
3.1. Hospitals - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2. Laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3. Independent physicians and clinics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 4. Cancer screening market in India - by screening type
4.1. Laboratory testing- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.2. Genetic testing- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.3. Imaging testing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.4. Biopsy testing- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.5. Endoscopy testing- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 5. Cancer screening market in India - by application
5.1. Lung cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.2. Breast cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.3. Melanoma cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.4. Kidney cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.5. Colorectal cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 6: Competitive landscape
6.1. F. Hoffmann-La Roche AG (*)
6.1. a. Company snapshot
6.1. b. Product offerings
6.1. c. Growth strategies
6.1. d. Initiatives
6.1. e. Geographical presence
6.1. f. Key numbers
6.2. GlaxoSmithKline PLC
6.3. Siemens Healthineers
6.4. Philips
6.5. GE Healthcare
(*) all the information are similar for the mentioned companies

Chapter 7: Conclusion

Chapter 8: Appendix
8.1. List of tables
8.2. Assumptions
8.3. Research and methodology
8.4. About Netscribes Inc.
Note: The Table of Contents (Toc) provided above contains the targeted coverage. The coverage is subject to change as we progress with the research. Disclaimer: The report will be delivered within 5-7 business days post payment confirmation
  • Global Interventional Oncology Market Size, Status and Forecast 2019-2025
    Published: 17-May-2019        Price: US 3900 Onwards        Pages: 110
    Interventional oncology is a subspecialty field of interventional radiology that deals with the diagnosis and treatment of cancerand cancer-related problems using targeted minimally invasive procedures performed under image guidance. Interventional oncology has developed to a separate pillar of modern oncology and it employs X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to help guide miniaturized instruments (e.g. biopsy needles, ablation electrodes, intr......
  • Global Lung Cancer Liquid Biopsy Market Size, Status and Forecast 2019-2025
    Published: 16-May-2019        Price: US 3900 Onwards        Pages: 91
    Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer. CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time. In 2018, the global Lung Cancer Liquid Biopsy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses ......
  • World Cancer Diagnostics Market, 2019-2023: Emerging Opportunities in the Americas, EMEA, APAC--A 75-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
    Published: 13-May-2019        Price: US 48500 Onwards        Pages: 1450
    This new 75-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years. The report provides granular market segmentation ana......
  • Asia-Pacific Cancer Diagnostics Market, 2019-2023: A 17-Country Analysis--Supplier Shares and Strategies, Emerging Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
    Published: 13-May-2019        Price: US 14500 Onwards        Pages: 935
    This new 17-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years. The report provides granular market segmentation analysi......
  • Europe Cancer Diagnostics Market, 2019-2023: A 31-Country Analysis--Supplier Shares and Strategies, Emerging Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
    Published: 13-May-2019        Price: US 37500 Onwards        Pages: 935
    This new 31-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years. The report provides granular market segmentation analysi......
  • Latin America Cancer Diagnostics Market, 2019-2023: A 7-Country Analysis--Supplier Strategies, Emerging Tumor Markers, Volume and Sales Forecasts, Technology and Instrumentation Review
    Published: 13-May-2019        Price: US 7850 Onwards        Pages: 550
    This new 7-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years. The report provides granular market segmentation analysis......
  • Middle East Cancer Diagnostics Market, 2019-2023: An 11-Country Analysis--Supplier Strategies, Emerging Tumor Markers, Volume and Sales Forecasts, Technology and Instrumentation Review
    Published: 13-May-2019        Price: US 9850 Onwards        Pages: 530
    This new 11-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years. The report provides granular market segmentation analysi......
  • North America Cancer Diagnostics Market Analysis, 2019-2023: Emerging Opportunities in the USA, Canada, Mexico--Supplier Shares and Strategies, Latest Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
    Published: 13-May-2019        Price: US 9700 Onwards        Pages: 630
    This new 3-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging opportunities and developing effective business strategies during the next five years. The report provides granular market segmentation analysis......
  • Global Cancer Diagnostics Market Analysis: Emerging Opportunities in the USA, Europe, Japan--Supplier Shares and Strategies, Latest Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation
    Published: 13-May-2019        Price: US 28500 Onwards        Pages: 1200
    LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Japan; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities fo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs